Efficacy of β-lactam/β-lactamase inhibitors to treat extended-spectrum beta-lactamase-producing Enterobacterales bacteremia secondary to urinary tract infection in kidney transplant recipients (INCREMENT-SOT Project)

Investigators from the REIPI/INCREMENT-SOT Group, Ligia C Pierrotti, Elena Pérez-Nadales, Mario Fernández-Ruiz, Belén Gutiérrez-Gutiérrez, Ban Hock Tan, Jordi Carratalà, Isabel Oriol, Mical Paul, Noa Cohen-Sinai, Francisco López-Medrano, Rafael San-Juan, Miguel Montejo, Maristela P Freire, Elisa Cordero, Miruna D David, Esperanza Merino, Seema Mehta Steinke, Paolo A Grossi, Ángela CanoElena M Seminari, Maricela Valerio, Filiz Gunseren, Meenakshi Rana, Alessandra Mularoni, Pilar Martín-Dávila, Christian van Delden, Melike Hamiyet Demirkaya, Zeliha Koçak Tufan, Belén Loeches, Ranganathan N Iyer, Fabio Soldani, Britt-Marie Eriksson, Benoît Pilmis, Marco Rizzi, Julien Coussement, Wanessa T Clemente, Emmanuel Roilides, Álvaro Pascual, Luis Martínez-Martínez, Jesús Rodríguez-Baño, Julian Torre-Cisneros, José María Aguado

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Efficacy of β-lactam/β-lactamase inhibitors to treat extended-spectrum beta-lactamase-producing Enterobacterales bacteremia secondary to urinary tract infection in kidney transplant recipients (INCREMENT-SOT Project)'. Together they form a unique fingerprint.

Medicine & Life Sciences